Nivolumab with chemotherapy in pleural mesothelioma after surgery: The NICITA trial. This is an ASCO Meeting Abstract from the 2023 ASCO Annual Meeting I. This abstract does not include a full text ...

Learn about mesothelioma prognosis, including factors that affect survival, life expectancy, treatment options, cancer stages, and ways to improve outcomes after diagnosis.

While many patients with mesothelioma — a type of rare cancer that most commonly occurs in the membrane between the lungs and the chest wall — may not be eligible to undergo surgery, drug advancements ...

Currently, there are few effective treatments for malignant mesothelioma, although it has been decades since it was found that the major risk factor is exposure to asbestos The drugs identified by ...

Mesothelioma is an aggressive tumor with a poor prognosis. Histological diagnosis of mesothelioma using limited tissue samples can be challenging. Carbonic anhydrase IX (CAIX) is a transmembrane ...

(a) Hematoxylin and eosin (H&E) stain (100×) on a needle biopsy specimen showing clusters of epithelioid tumor cells in a fibrotic stroma. (b) Corresponding area to (a) with positive nuclear and ...

A cancer diagnosis is never good news – and a diagnosis of malignant mesothelioma may be the worst news of all. However, an innovative therapy, developed by Professor Peter Szlosarek and his team in ...

Malignant mesothelioma, often shortened as mesothelioma, is a rare form of malignancy caused by exposure to asbestos. Asbestos are naturally occurring fiber-like minerals that have unique ...

When Les Morris worked as a carpenter cutting up building materials in the 1970s with South Sydney council, he knew nothing about the danger of asbestos. "I would be covered in it," Mr Morris said. "I ...

Phase 2 study to evaluate the novel mitochondrial PRX3 inhibitor, RSO-021, as an intrapleural monotherapy and in combination with IV paclitaxel in patients with malignant pleural effusion due to ...